AbbVie
ABBV
$312.29
Share price
3.31%
Change (1 day)
10.47%
Change (1 year)
Categories
The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol “ABBV”.
AbbVie (ABBV) - Net assets
Net assets on the balance sheet as of December 2024 : NZ$5.63 Billion
According to AbbVie's latest financial reports the company has NZ$5.63 Billion in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
AbbVie - Net assets on balance sheet (from 2011 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2024-12-31 | $NZ$5.96 B | -63.72% |
| 2023-12-31 | $NZ$16.44 B | -39.62% |
| 2022-12-31 | $NZ$27.22 B | 20.48% |
| 2021-12-31 | $NZ$22.59 B | 24.5% |
| 2020-12-31 | $NZ$18.15 B | -249.59% |
| 2019-12-31 | $-NZ$12.14 Billion | -3.63% |
| 2018-12-31 | $-NZ$12.6 Billion | -275.45% |
| 2017-12-31 | $NZ$7.17 B | 7.23% |
| 2016-12-31 | $NZ$6.69 B | 16.11% |
| 2015-12-31 | $NZ$5.76 B | 159.25% |
| 2014-12-31 | $NZ$2.22 B | -59.33% |
| 2013-12-31 | $NZ$5.46 B | 33.71% |
| 2012-12-31 | $NZ$4.08 B | -73.26% |
| 2011-12-31 | $NZ$15.28 B | -24.89% |
| 2010-12-31 | $NZ$20.35 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 | NZ$148.31 B | 2,530.71% | 🇺🇸 USA |
 | NZ$27.46 B | 387.16% | 🇺🇸 USA |
 | NZ$23.91 B | 324.24% | 🇺🇸 USA |
 | NZ$9.84 B | 74.70% | 🇺🇸 USA |
 | NZ$32.25 B | 472.12% | 🇺🇸 USA |
 | NZ$28.01 B | 396.91% | 🇺🇸 USA |
 | NZ$27.52 B | 388.16% | 🇬🇧 UK |
 | NZ$68.49 B | 1,114.95% | 🇬🇧 UK |
 | NZ$4.34 B | -23.02% | 🇺🇸 USA |